Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Profound Medical (PROF) EBIT Margin (2024 - 2025)

Profound Medical (PROF) has 2 years of EBIT Margin data on record, last reported at 440.1% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 62696.0% year-over-year to 440.1%; the TTM value through Dec 2025 reached 39.43%, up 27014.0%, while the annual FY2025 figure was 39.43%, 27014.0% up from the prior year.
  • EBIT Margin reached 440.1% in Q4 2025 per PROF's latest filing, up from 168.52% in the prior quarter.
  • Across five years, EBIT Margin topped out at 440.1% in Q4 2025 and bottomed at 646.19% in Q1 2024.